Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1086 studies found for:    "Hodgkin Disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Hodgkin Disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Mantle Irradiation for Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Procedure: Mantle irradiation
2 Completed A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: MDX-060
3 Terminated Breast-Sparing Proton Therapy for Hodgkin's Disease
Condition: Hodgkins Disease
Intervention: Radiation: Proton
4 Completed
Has Results
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: G-CSF Plus Plerixafor
5 Unknown  Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: R-mabHD;   Drug: ABVD
6 Completed Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)
Condition: Hodgkin's Disease
Interventions: Drug: Methotrexate;   Drug: Leucovorin calcium;   Drug: 6-Thioguanine
7 Completed Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: Gemcitabine;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Antithymocyte Globulin;   Procedure: Allogeneic Stem Cell Infusion;   Drug: Tacrolimus;   Drug: Filgrastim (G-CSF);   Drug: Methotrexate
8 Completed Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy
Condition: Hodgkin Disease
Interventions: Drug: Filgrastim SD/01;   Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: DTIC
9 Active, not recruiting Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Condition: Hodgkin's Disease
Intervention: Procedure: Echo/Stress Echo
10 Terminated Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
Condition: Hodgkin Disease
Interventions: Drug: Doxorubicin;   Drug: Vinblastine;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Prednisone
11 Completed Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
Condition: Hodgkin's Disease
Interventions: Procedure: Pulmonary Function Tests;   Procedure: CAT Scan
12 Completed Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)
Condition: Advanced Hodgkin Disease
Intervention: Drug: COPPEBVCAD vs BEACOPP vs ABVD
13 Unknown  Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
Condition: Hodgkin Disease
Interventions: Drug: Combined chemotherapy (ABVD, BACOPP-D);   Procedure: Radiation therapy
14 Completed A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Ifosfamide, Gemcitabine, Vinorelbine;   Drug: Bortezomib + IGEV
15 Not yet recruiting A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Brentuximab vedotin;   Drug: Doxorubicin;   Drug: Vinblastine;   Drug: Dacarbazine
16 Completed A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Conditions: Pediatric;   Hodgkin's Disease
Interventions: Drug: COPP/ABV;   Drug: intensive chemo with concurrent growth factor
17 Recruiting Brazilian Prospective Hodgkin Lymphoma Registry
Conditions: Hodgkin Lymphoma;   Hodgkin Disease
Intervention:
18 Terminated Personalised Program for Women Treated for Hodgkin Disease
Conditions: Hodgkin Disease;   Breast Cancer
Intervention: Procedure: intensive screening
19 Active, not recruiting
Has Results
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
Conditions: Lymphoma;   Hodgkin's Disease
Interventions: Drug: Melphalan;   Drug: Ara-C;   Drug: VP-16;   Drug: BCNU;   Drug: Rituxan;   Drug: Stem Cells
20 Recruiting Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
Condition: Hodgkin's Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.